Keyphrases
Low Prevalence
100%
High Normal
100%
Atrial Natriuretic Peptide
100%
Insulin Resistance
100%
NT-proANP
80%
Glucose-dependent Insulinotropic Polypeptide
60%
Glucagon-like
40%
Linear Regression Analysis
40%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
40%
Low Risk
40%
Glucose Consumption
40%
Diabetes Development
20%
Logistic Regression Analysis
20%
Glucagon
20%
Decreased Risk
20%
Malm
20%
Incretin Secretion
20%
Peptide Release
20%
Upper Quartile
20%
Confidence Interval
20%
Odds Ratio
20%
Plasma Parameters
20%
Insulin
20%
Oral Glucose Tolerance Test
20%
Non-diabetic
20%
Neuropeptide Secretion
20%
Medicine and Dentistry
Atrial Natriuretic Factor
100%
Insulin Resistance
100%
Prevalence
100%
Gastric Inhibitory Polypeptide
60%
Homeostatic Model Assessment
40%
Glucagon Like Peptide 1
40%
Linear Regression Analysis
40%
Glucose Intake
40%
Secretion (Process)
40%
Glucagon
20%
Odds Ratio
20%
Cardiovascular System
20%
Diet and Cancer
20%
Logistic Regression Analysis
20%
Diabetes
20%
Incretin
20%
Oral Glucose Tolerance Test
20%
Nursing and Health Professions
Prevalence
100%
Insulin Resistance
100%
Atrial Natriuretic Factor
100%
Gastric Inhibitory Polypeptide
60%
Homeostasis Model Assessment
40%
Glucose Intake
40%
Glucagon Like Peptide 1
40%
Linear Regression Analysis
40%
Confidence Interval
20%
Oral Glucose Tolerance Test
20%
Cardiovascular System Cancer
20%
Incretin
20%
Odds Ratio
20%
Logistic Regression Analysis
20%
Blood Level
20%
Glucagon
20%
Biochemistry, Genetics and Molecular Biology
Atrial Natriuretic Peptide
100%
Prevalence
100%
Insulin Resistance
100%
Gastric Inhibitory Polypeptide
42%
Homeostasis
28%
Secretion (Process)
28%
Glucagon-Like Peptide-1
28%
Glucose Test
14%
Glucose Tolerance Test
14%
Glucagon
14%
Incretin
14%
Blood Level
14%
Neuroscience
Atrial Natriuretic Peptide
100%
Gastric Inhibitory Polypeptide
60%
Glucagon-Like Peptide-1
40%
Glucose Tolerance Test
20%
Incretin
20%
Glucagon
20%
Blood Plasma
20%
Psychology
Insulin Resistance
100%
Linear Regression
28%
Regression Analysis
14%